SOL S.p.A. Stock

Equities

SOL

IT0001206769

Commodity Chemicals

Market Closed - Borsa Italiana 11:44:59 2024-04-26 am EDT 5-day change 1st Jan Change
35 EUR +1.01% Intraday chart for SOL S.p.A. +1.60% +25.90%
Sales 2024 * 1.6B 1.71B Sales 2025 * 1.72B 1.83B Capitalization 3.17B 3.39B
Net income 2024 * 161M 172M Net income 2025 * 174M 186M EV / Sales 2024 * 2.26 x
Net Debt 2024 * 429M 459M Net Debt 2025 * 424M 453M EV / Sales 2025 * 2.1 x
P/E ratio 2024 *
19.7 x
P/E ratio 2025 *
18.2 x
Employees 6,372
Yield 2024 *
1.26%
Yield 2025 *
1.37%
Free-Float 36.98%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.01%
1 week+1.60%
Current month+5.58%
1 month+11.11%
3 months+32.33%
6 months+30.84%
Current year+25.90%
More quotes
1 week
33.90
Extreme 33.9
35.60
1 month
32.15
Extreme 32.15
35.80
Current year
25.60
Extreme 25.6
35.80
1 year
24.00
Extreme 24
35.80
3 years
15.12
Extreme 15.12
35.80
5 years
8.00
Extreme 8
35.80
10 years
5.51
Extreme 5.51
35.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 90-09-03
Chief Executive Officer 66 90-05-14
Director of Finance/CFO - -
Members of the board TitleAgeSince
Chief Executive Officer 66 90-05-14
Chief Executive Officer 62 90-09-03
Director/Board Member 65 98-04-26
More insiders
Date Price Change Volume
24-04-26 35 +1.01% 18,065
24-04-25 34.65 0.00% 27,699
24-04-24 34.65 -1.14% 38,236
24-04-23 35.05 +1.30% 11,887
24-04-22 34.6 +0.44% 24,032

Real-time Borsa Italiana, April 26, 2024 at 11:44 am EDT

More quotes
SOL SpA is an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases. It is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
35 EUR
Average target price
38 EUR
Spread / Average Target
+8.57%
Consensus

Annual profits - Rate of surprise